Among active 13F managers last quarter, 3 opened and 1 reduced; the largest holder to move was Citadel Advisors LLC (new position). No open-market insider trades in the last 180 days.
Funds lean in and no leg opposes.
25 tracked 13F filers disclose a position in APRE as of the latest SEC 13F filings, a combined $1.8M in reported value. Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
| # | Fund | Shares | Position value | Last move | As of | History |
|---|---|---|---|---|---|---|
| 1 | AIGH Capital Management LLC | 1.0M | $815K | —Held | Q2 2026 | |
| 2 | Vestal Point Capital, LP | 350K | $281K | —Held | Q2 2026 | |
| 3 | Sphera Funds Management LTD. | 270K | $217K | —Held | Q2 2026 | |
| 4 | Nantahala Capital Management, LLC | 206K | $165K | —Held | Q2 2026 | |
| 5 | Geode Capital Management, LLC | 75K | $60K | ▼−37% Reduced · −44K sh | Q2 2026 | |
| 6 | Citadel Advisors LLC | 59K | $47K | ▲New +59K sh | Q2 2026 | |
| 7 | Diadema Partners LP | 45K | $36K | ▲New +45K sh | Q2 2026 | |
| 8 | BNP Paribas Financial Markets | 40K | $30K | ▲+46% Added · +12K sh | Q1 2026 | |
| 9 | Vanguard Fiduciary Trust Co | 38K | $31K | —Held | Q2 2026 | |
| 10 | Renaissance Technologies LLC | 25K | $19K | ▲New +25K sh | Q1 2026 | |
| 11 | Vanguard Capital Management LLC | 23K | $18K | ▲+17% Added · +3K sh | Q2 2026 | |
| 12 | Morgan Stanley | 22K | $17K | ▼−71% Reduced · −55K sh | Q1 2026 | |
| 13 | LPL Financial LLC | 21K | $16K | ▼−19% Reduced · −5K sh | Q1 2026 | |
| 14 | HighTower Advisors, LLC | 14K | $11K | —Held | Q1 2026 | |
| 15 | Susquehanna International Group, LLP | 13K | $10K | ▲New +13K sh | Q1 2026 | |
| 16 | Persistent Asset Partners Ltd | 11K | $9K | ▲New +11K sh | Q2 2026 | |
| 17 | BlackRock, Inc. | 7K | $6K | ▼−16% Reduced · −1K sh | Q2 2026 | |
| 18 | Tower Research Capital LLC (TRC) | 5K | $4K | ▼−34% Reduced · −3K sh | Q1 2026 | |
| 19 | UBS Group AG | 2K | $2K | ▼−13% Reduced · −308 sh | Q1 2026 | |
| 20 | Group One Trading LLC | 577 | $463 | —Held | Q2 2026 | |
| 21 | Osaic Holdings, Inc. | 295 | $225 | ▼−1.7% Reduced · −5 sh | Q1 2026 | |
| 22 | WealthCollab, LLC | 158 | $127 | —Held | Q2 2026 | |
| 23 | Integrated Wealth Concepts LLC | 46 | $36 | ▲New +46 sh | Q2 2026 | |
| 24 | FMR LLC | 45 | $36 | ▲New +45 sh | Q2 2026 | |
| 25 | SBI Securities Co., Ltd. | 16 | $13 | —Held | Q2 2026 |
Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
Last quarter, 3 funds opened a new position in APRE, while 1 reduced. Based on 13F filings from active, signal-eligible managers (passive index funds and other mechanical holders are excluded from this count).
| Company | Co-held by | Their position there |
|---|---|---|
| Novo-Nordisk A/s-Spons ADRNVO | 7 funds | $133.4M |
| Bristol-Myers Squibb CoBMY | 7 funds | $124.0M |
| Cogent Biosciences IncCOGT | 7 funds | $96.9M |
| Dyne Therapeutics IncDYN | 7 funds | $85.6M |
| Cellebrite Di LtdCLBT | 7 funds | $48.3M |
| Verastem IncVSTM | 7 funds | $23.1M |
| United Therapeutics CorpUTHR | 6 funds | $1.1B |
| Sandisk CorpSNDK | 6 funds | $896.2M |
| Neurocrine Biosciences IncNBIX | 6 funds | $484.0M |
| Intel CorpINTC | 6 funds | $475.3M |
| Unitedhealth Group IncUNH | 6 funds | $327.7M |
| Biomarin Pharmaceutical IncBMRN | 6 funds | $272.8M |
Ranked by how many of APRE's tracked holders also hold each name. The last column is those co-holders' combined reported position in that name, not in APRE.
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| Jan 30, 2026 | Hamill John P. | SrVP/CFO/Prin Fin & Acct Ofcr | Buy (P) | 6K | $5K |
| Jan 30, 2026 | Gilad Oren | President/CEO, Director | Buy (P) | 28K | $25K |
| Dec 10, 2025 | Hamill John P. | SrVP/CFO/Prin Fin & Acct Ofcr | Buy (P) | 5K | $6K |
| Dec 10, 2025 | Duey Marc | Director | Buy (P) | 21K | $25K |
| Apr 3, 2025 | Gilad Oren | President/CEO, Director | Buy (P) 2 lots, same day | 6K | $10K |
| Oct 23, 2024 | Gilad Oren | President/CEO, Director | Buy (P) | 500 | $2K |
| Oct 18, 2024 | Duey Marc | Director | Sell (S) | 6K | $30K |
| Oct 16, 2024 | Duey Marc | Director | Buy (P) | 30K | $132K |
| Oct 15, 2024 | Gilad Oren | President/CEO, Director | Buy (P) | 250 | $725 |
| Oct 14, 2024 | Gilad Oren | President/CEO, Director | Buy (P) | 1K | $3K |
| Oct 14, 2024 | Duey Marc | Director | Buy (P) | 190 | $490 |
| Oct 11, 2024 | Seizinger Bernd R. | Director | Buy (P) | 10K | $27K |
One row per insider, day and transaction code; shares and value are summed across the lots. Every lot is on the full insider page and in the filing.
Where institutional funds (13F), corporate insiders (Form 4) and US House members (STOCK Act) are buying or selling the same name in the same window. Green is buying, red is selling.
Insiders and Congress: last 180 days. Funds: latest 13F, top 100 holders incl. passive
| Source | Buying | Selling | Net |
|---|---|---|---|
13F funds Top 100 holders by value, passive included; the hero counts active managers only | 2 | 7 | – |
Insiders Form 4 open-market | 0 | 0 | $0 |
US House STOCK Act trades | 0 | 0 | $0 |
Capital Rotation reports where institutional capital disclosed rotating, as of the latest public SEC 13F filings. It is data, not investment advice, a recommendation, or a prediction. Filings lag about 45 days and cover long US equity positions only. Past disclosed flows do not indicate future prices. Do your own research; consult a licensed advisor.
Connected entities for APRE
This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/stocks/APRE/capital-change-brief"
Use Arkolith's capital_change_brief for APRE. Tell me what changed, whether insider activity corroborates it, and cite the SEC evidence.
13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for APRE. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes.